triamcinolone has been researched along with Invasiveness, Neoplasm in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujiwara, Y; Fukunaga, S; Hosomi, S; Ishihara, T; Kamata, N; Nagami, Y; Ominami, M; Otani, K; Sakai, T; Shiba, M; Sugimori, S; Taira, K; Tanaka, F; Tanigawa, T; Watanabe, T; Yamagami, H; Yamamoto, K | 1 |
Barwe, SP; Damoiseaux, R; Franco, OE; Grubbs, SS; Hayward, SW; Huynh, TP; Lee, SJ; McSpadden, R; Petrelli, NJ; Rajasekaran, AK | 1 |
2 other study(ies) available for triamcinolone and Invasiveness, Neoplasm
Article | Year |
---|---|
Prediction of esophageal stricture in patients given locoregional triamcinolone injections immediately after endoscopic submucosal dissection.
Topics: Aged; Cohort Studies; Endoscopic Mucosal Resection; Esophageal Neoplasms; Esophageal Stenosis; Esophagoscopy; Female; Humans; Injections, Intralesional; Logistic Models; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Postoperative Complications; Predictive Value of Tests; Prognosis; Propensity Score; Retrospective Studies; ROC Curve; Treatment Outcome; Triamcinolone | 2018 |
Glucocorticoids suppress renal cell carcinoma progression by enhancing Na,K-ATPase beta-1 subunit expression.
Topics: Animals; Carcinoma, Renal Cell; Cell Adhesion; Cell Line, Tumor; Dexamethasone; Disease Progression; Fluorometholone; Glucocorticoids; HeLa Cells; High-Throughput Screening Assays; Humans; Kidney Neoplasms; Male; Mice; Mice, Hairless; Mice, SCID; Neoplasm Invasiveness; Promoter Regions, Genetic; RNA, Messenger; RNA, Neoplasm; Sodium-Potassium-Exchanging ATPase; Triamcinolone; Up-Regulation; Xenograft Model Antitumor Assays | 2015 |